Evidence map›Paper›PMID 34037705›Full record

ArticleJAMA surgery2021

Association of High Burden of End-stage Kidney Disease With Decreased Kidney Transplant Rates With the Updated US Kidney Allocation Policy.

Derek A DuBay, Thomas Anthony Morinelli, Zemin Su, Patrick Mauldin, Erin Weeda, Michael J Casey, Prabhaker Baliga, David J Taber

Abstract read
In one paragraph

Article in JAMA surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Increased volume of organ offers and decreased efficiency of kidney placement under circle-based kidney allocation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Article
  2. Effect of Policy on Geographic Inequities in Kidney Transplantation.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2022
    Article
  3. One-Year Experience With the New Kidney Allocation Policy at a Single Center and an OPO in the Midwestern United States.Transplant international : official journal of the European Society for Organ Transplantation · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Derek A DuBayDivision of Transplant Surgery, Department of Surgery, Medical University of South Carolina, Charleston.
Thomas Anthony MorinelliDivision of Transplant Surgery, Department of Surgery, Medical University of South Carolina, Charleston.
Zemin SuGeneral Internal Medicine/Geriatrics, Department of Medicine, Medical University of South Carolina, Charleston.
Patrick MauldinGeneral Internal Medicine/Geriatrics, Department of Medicine, Medical University of South Carolina, Charleston.
Erin WeedaDepartment of Clinical Pharmacy and Outcomes Sciences, Medical University of South Carolina, Charleston.
Michael J CaseyDivision of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston.
Prabhaker BaligaDivision of Transplant Surgery, Department of Surgery, Medical University of South Carolina, Charleston.
David J TaberDivision of Transplant Surgery, Department of Surgery, Medical University of South Carolina, Charleston.

Funding

Proteomics CoreP30DK123704 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DON C. ROCKEY · 2020 to 2026
$8.8M
6 · The paper itself

Abstract

Importance: The Organ Procurement and Transplantation Network (OPTN) approved changes to the US kidney allocation system in 2019. The potential effects of this policy change using transplant rates normalized to end-stage kidney disease (ESKD) incidence have not been investigated. Objective: To estimate how the OPTN kidney allocation policy will affect areas of the US currently demonstrating low rates of kidney transplant, when accounting for the regional burden of ESKD. Design, Setting, and Participants: This cross-sectional population-based economic evaluation analyzed access of patients with ESKD to kidney transplant in the US. Participants included patients with incident ESKD, those on the kidney transplant wait list, and those who received a kidney transplant. Data were collected from January 1 to December 31, 2017, and were analyzed in 2019. Main Outcomes and Measures: The probability of a patient with ESKD being placed on the transplant wait list or receiving a deceased donor kidney transplant. States and donor service areas (DSAs) were compared for gains and losses in rates of transplanted kidneys under the new allocation system. Transplant rates were normalized for ESKD burden. Results: A total of 122 659 patients had incident ESKD in the US in 2017 (58.2% men; mean [SD] age, 62.8 [15.1] years). The probability of a patient with ESKD receiving a deceased donor kidney transplant varied 3-fold across the US (from 6.36% in West Virginia to 18.68% in the District of Columbia). Modeling of the OPTN demonstrates that DSAs from New York (124%), Georgia (65%), and Illinois (56%) are estimated to experience the largest increases in deceased donor kidney allocation. Other than Georgia, these states have kidney transplant rates per incident ESKD cases above the mean (of 50 states plus the District of Columbia, New York is 16th and Illinois is 24th). In contrast, DSAs from Nevada (-74%), Ohio (-67%), and North Carolina (-61%)-each of which has a transplant rate per incident ESKD cases significantly below the mean-are estimated to experience the largest decreases in deceased donor allocation (of 50 states plus the District of Columbia, North Carolina is 34th, Ohio is 38th, and Nevada is 47th). Conclusions and Relevance: The new OPTN-approved kidney allocation policy may result in worsening geographic disparities in access to transplants when measured against the burden of ESKD within a particular region of the US.

Indexed as

Health PolicyPatient SelectionAdolescentAdultAgedAged, 80 and overCost of IllnessCross-Sectional StudiesFemaleHumansIncidenceKidney Failure, ChronicKidney TransplantationMaleMiddle AgedTissue and Organ Procurement

Identifiers

PMID34037705
PMCPMC8156168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.